Author:
Han Jiangbin,Sun Jiye,Sha Chunjie,Zhang Jinfeng,Gai Yunyun,Li Youxin,Liu Wanhui
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference11 articles.
1. Inhibition of prostate tumor growth in two rats models by chronic administration of D-Trp-6 analogue of luteinizing hormone–releasing hormone;Redding;Proc. Natl. Acad. Sci. U.S.A.,1981
2. Growth of human breast cancer cells inhibited by a luteinizing hormone–releasing hormone agonist;Miller;Nature,1985
3. Combined treatment with LHRH agonist and pure antiandrogen in advanced carcinoma of prostate;Labile;Lancet,1984
4. From contraception to cancer: a review of the therapeutic applications of LHRH analogues as antitumor agents;Corbin;Yale J. Biol. Med.,1982
5. The half-life, metabolismand excretion of titrated luteinizing hormone–releasing hormone (LH–RH) in man;Redding;J Clin. Endocrinol. Metab.,1973